Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Intake of the green tea catechin epigallocatechin (EGCG) increased fat oxidation during walking. It is also known to reduce blood pressure and improve body composition. This research will expand the insight on the effects by Matcha green tea supplementation and address the effects on heart rate variability, substrate oxidation at rest, and cardiovascular responses at rest in addition to metabolic and physiologic responses for a 1-hr walk in healthy females.
Intake of the catechin epigallocatechin (EGCG) increased fat oxidation during walking. It is also known to reduce blood pressure and improve body composition. EGCG is the most abundant and potent bioactive compound (50-80% of the total catechin content) found in Matcha green tea (MGT) and is usually consumed as a drink or in a capsulated from unfermented tea leaves. MGT polyphenols have antioxidant and anti-inflammatory properties, providing numerous health benefits, such as the reduced risk of type 2 diabetes and obesity. MGT supplementation (3g over a 24hr period) has been shown to enhance fat oxidation during 30-min brisk walking as well as lower respiratory exchange ratio in females. Understanding the effectiveness of the bioactive compounds found in natural food sources in improving human health is key to informing the general population and the public health policies preceding them; the daily consumption of drinks and food naturally high in EGCG content could be recommended as an essential part of a healthy lifestyle. This research will expand the insight on Matcha green tea supplementation address the effect on heart rate variability, substrate oxidation at rest, and cardiovascular responses at rest in addition to metabolic and physiologic responses for a 1-hr walk in healthy females.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo | Experimental | Participants will be supplemented with a placebo. |
|
| Matcha green tea | Experimental | Participants will be supplemented with Matcha green tea. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Matcha green tea | Dietary Supplement | This is the condition with the Matcha green tea |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Heart rate variability | Measurement of root mean square of standard deviation of RR intervals | Three weeks |
| Carbohydrate oxidation | Measurement of carbohydrate oxidation in grams/minute | Three weeks |
| Fat oxidation | Measurement of fat oxidation in grams/minute | Three weeks |
| Cardiac output | Measurement of cardiac output in liters per minute | Three weeks |
| Stroke volume | Measurement of stroke volume in milliliters | Three weeks |
| Total peripheral resistance | Measurement of total peripheral resistance in (mmHg x min) / mL | Three weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mark E Willems | University of Chichester | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mark Willems | Chichester | West Sussex | PO19 6PE | United Kingdom | ||
| University of Chichester |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Randomized, placebo-controlled, crossover design
Not provided
Not provided
Not provided
| Placebo |
| Dietary Supplement |
This is the condition with the placebo |
|
| Chichester |
| United Kingdom |